PILMA Calls for PBM Reform in the 119th Congress
The Honorable Brett Guthrie, Chairman House Committee on Energy and Commerce 2161 Rayburn House Office Building, Washington, DC 20515 The Honorable Representative Frank Pallone, Ranking Member House Committee on Energy and Commerce 2125 Rayburn House Office Building, Washington, DC 20515 The Honorable Representative Jason Smith, Chairman House Committee on Ways and Means 1011 Longworth House Office Building, Washington, DC 20515 […]
PRESS RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End
December 5, 2025 FOR IMMEDIATE RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) today applauded Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) for introducing the bipartisan Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act. […]
Senate HELP: PBM transparency and reform letter
December 3, 2025 The Honorable Bill Cassidy, ChairmanSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 The Honorable Bernie Sanders, Ranking MemberSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 Dear Senators Cassidy and Sanders, We write today on behalf of the Pharmaceutical […]
A $416 Million Hit to Union Workers: New Research Highlights How the 340B Program Drives Up Costs for Taft-Hartley Plans
A recent study found that a little-known federal program may be driving up union healthcare costs by as much as $416 million per year. The 340B program was created more than 30 years ago to help safety-net providers serve low-income communities by offering prescription drugs at steep discounts. Over time, however, the program has expanded […]
Foreign Reference Pricing Threatens Union Jobs, American Global Leadership
FOR IMMEDIATE RELEASEAugust 7, 2025 Importing foreign prices would undermine life science innovation, eliminate union jobs, and cede ground to China The Pharmaceutical Industry Labor-Management Association (PILMA) expresses deep concern over recent White House actions that aim to implement a “Most Favored Nation” (MFN) pricing policy for prescription drugs. This misguided approach poses a serious […]
Letter to HELP Committee on PBMs
July 31, 2025 The Honorable Bill Cassidy, Chairman Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 Dear Chairman Cassidy and Ranking Member Sanders, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) […]
PRESS RELEASE New Study Demonstrates Critical Role of American Workers in Building Life-Saving Medicine Infrastructure
June 17, 2025 Research shows the U.S. pharmaceutical industry generated 65 million labor hours and $2.6 billion in wages for skilled union workers who built and maintained advanced pharmaceutical manufacturing facilities across 18 states over the past five years. The Pharmaceutical Industry Labor-Management Association (PILMA) today released groundbreaking research demonstrating the pharmaceutical and biotech industries’ […]
Statement on Executive Order
PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action April 17, 2025 Bipartisan EPIC Act offers solution to protect patient access, pharmaceutical The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes renewed attention to the harmful impacts of the Inflation Reduction Act’s so-called “pill penalty,” highlighted in the April 15 Presidential Executive Order. The pill […]
The Feds must stop going easy on foreign patent thieves who hurt Pennsylvania | Opinion
Ron KlinkSpecial to the USA TODAY NetworkApril 4, 2025 Key Points In the past few months, researchers at the University of Pittsburgh have received more than a dozen patents, including for an experimental probiotic weight-loss therapy, a more durable and flexible solar cell and a new method of detecting and treating pancreatic cancer.But Pitt doesn’t […]
PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act
February 25, 2025 PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act Bipartisan legislation would correct the “pill penalty” to safeguard union jobs and ensure continued innovation in small-molecule therapies The Pharmaceutical Industry Labor-Management Association (PILMA) applauds the introduction of the Ensuring Pathways to Innovative Cures (EPIC) Act (H.R. 1492), a bipartisan […]